Updates are available Correction dated 2026-06-30

Article History

Received: 19 December 2025

Accepted: 31 March 2026

First Online: 6 May 2026

Change Date: 30 June 2026

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s11523-026-01229-w

Declarations

:

: Koichi Goto has received grants from Nippon Boehringer Ingelheim Co., Ltd, Bayer Yakuhin, Ltd, and Daiichi Sankyo Co., Ltd; has received consulting fees or honorarium for Nippon Boehringer Ingelheim Co., Ltd, Boehringer Ingelheim Taiwan, Bayer HealthCare Pharmaceuticals lnc., and Daiichi Sankyo Co., Ltd; has received payment for writing or reviewing the manuscript for Daiichi Sankyo Co., Ltd; and has received payment for lectures including service on speakers bureaus for Boehringer Ingelheim Taiwan and Bayer HealthCare Pharmaceuticals lnc. Hidetoshi Hayashi has received grants or research funding from A2 Healthcare Corp., AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca K.K., Bristol Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., CMIC Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Inc., EPS Corporation, GlaxoSmithKline K.K., ICON Clinical Research GK, IQVIA Services Japan K.K., Janssen Pharmaceutical K.K., MSD K.K., Nippon Boehringer Ingelheim Co., Ltd., PPD-SNBL K.K., PRA Health Sciences Inc., Pfizer R&D Japan G.K., Sanofi K.K., Sysmex Corporation, Syneos Health Clinical K.K., Taiho Pharmaceutical Co., Ltd., and WJOG (West Japan Oncology Group); has received consulting fees or honoraria from AbbVie Inc., Amgen Inc., AstraZeneca K.K., Bristol Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., MSD K.K., Ono Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd.; and has received payment for writing or reviewing the manuscript from Guardant Health Japan Corp. and Ono Pharmaceutical Co., Ltd. Sonia S. Maruti is an employee of Boehringer Ingelheim. Heiko Zettl is employed by Boehringer Ingelheim International GmbH. Lalith Mittal is an employee of Evidera Inc., Thermofisher Scientific, a company that received funding from Boehringer Ingelheim to conduct this study. Smit Pathak reports consulting fees or honoraria and is an employee of Evidera Inc. and Thermo Fisher Scientific, companies that received funding from Boehringer Ingelheim. Xiuning Le has received consulting or advisory fees from AbbVie, Abion, Akeso, Allist, ArriVent, AstraZeneca, Avistone, Bayer, BioNTech, BlossomHill, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Dizal, Eli Lilly, EMD Serono (Merck KGaA), Hengrui, Innovent, Johnson & Johnson (Janssen), Merck, Novartis, Pfizer, Regeneron, Summit, SystImmune, Taiho, and Teligene, and has received research funding to her institution from ArriVent, Dizal, Eli Lilly, EMD Serono, Johnson & Johnson (Janssen), Regeneron, Takeda, Teligene, and Thermo Fisher.

: Not applicable.

: Not applicable.

: All authors made substantial contributions to the conception or design of the work and/or to the acquisition, analysis, or interpretation of the data. All authors participated in drafting the manuscript or revising it critically for important intellectual content. All authors provided final approval of the version to be published and agree to be accountable for all aspects of the work, ensuring that any questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.